In response to the growing demand for personal protective equipment (PPE) in health institutions, our PharmE3D Lab is using its 3D-printing resources to fabricate face shields for Dell Medical School and other health institutions. The project, called RAPID Shield, leverages the lab’s quick turnaround to meet demand until stocks can be replenished.
Our PharmE3D and 3DBioP Labs are leveraging its resources to print personalised nasal swabs for COVID-19 test kit. In response to the growing need of increased tests per day, the lab is now in a process to ramp-up its facility to produce ~30000 kits per day. Our group has so far printed and provided prototype swabs to City of Austin, Austin Public Health and Central Pathology Lab (CPL). We have also developed ‘PharmE3D’ design of our own nasal swabs that can contain more fluid compared to those available in open source platform. Initial testing by CPL has confirmed that our swabs are safe for human use. These are made of FDA approved medical grade biomaterials and are fully biocompatible, non-toxic, and non-mutagenic.
nParticl3D (OSP 202001672-001):
Novel hybrid anti-viral smart drug delivery system (nParticl3D) to treat COVID-19 (June 2020- Feb 2021): This recently sponsored project supports the adaption of a first-of-its-kind 3D printing process to fabricate smart system with tunable shape and morphology of the resultant particles for fighting SARS-CoV-2 type pathogens. Our developed Drug Delivery System (DDS) matches the route of medication to the route of infection and is faster, economically feasible and green.
Latest News, Interviews, and Features: